Drugs.com - Clinical Trials

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

DEER PARK, Ill., March 14, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare...

Mar 18, 2025 - 01:11
 0
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
DEER PARK, Ill., March 14, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare...
Read More

Tags:

Previous Article

Zentalis Pharmaceuticals Presents Updated Azenosertib Clinical Data at the Socie...

Next Article

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human ...

Related Posts

Clarity Receives US FDA Fast Track Designation for the Treatment of Metastatic Castration-Resistant Prostate Cancer Patients with Cu-67 SAR-bisPSMA

Clarity Receives US FDA Fast Track Designation for the ...

Feb 20, 2025  0

CagriSema Demonstrates Superior Weight Loss in Adults with Obesity or Overweight and Type 2 Diabetes in the REDEFINE 2 Trial

CagriSema Demonstrates Superior Weight Loss in Adults w...

Mar 11, 2025  0

U.S. FDA Accepts Gilead’s New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review

U.S. FDA Accepts Gilead’s New Drug Applications for Twi...

Feb 27, 2025  0